Matthew J Akiyama
Datos Biográficos
| ID | 6058342 |
|---|---|
| NOMBRE | Matthew J Akiyama |
| NOMBRES | Matthew J |
| APELLIDO | Akiyama |
| FIRMA | AKIYAMA M J |
| AFILIACIONES | Albert Einstein College of Medicine |
| ORCID | 0000-0003-4290-3083 |
| VERIFICADO | Sí |
| TOTAL DE OBRAS | 26 |
| TOTAL DE CITAS | 0 |
| TOTAL COMO AUTOR | 26 |
| TOTAL COMO EDITOR | 0 |
| PRIMER AÑO DE PUBLICACIÓN | 2016 |
| AÑO MÁS RECIENTE DE PUBLICACIÓN | 2026 |
| ÍNDICE H | 0 |
Budget impact of wastewater surveillance for Covid-19 in a large urban jail
Background: Correctional facilities were disproportionately affected by SARS-CoV-2 (COVID-19) outbreaks. Wastewater surveillance programs (WSP) may provide early warnings of the presence of COVID-19 and facilitate the timely implementation of infection mitigation, but their budgetary implications for correctional systems remain unclear. Methods: We conducted an activity-based costing analysis of a pilot WSP in a large urban jail. Costs borne by t…
Feasibility and acceptability of peer navigator-led directly-observed-therapy to promote concordance with antiretroviral therapy among criminal legal system-involved individuals
Gender differences in social networks of women and men who inject drugs in Kenya
Hepatitis C treatment in a jail setting
Jail-based HCV treatment initiation is feasible. However, individuals released with medication face challenges in linkage to care. Improved discharge planning and community linkage are critical to post-release treatment success
Interventions to improve testing, linkage to care, and treatment for hepatitis C infection in prison
Barriers to and impacts of hepatitis C treatment among people who inject drugs in Kenya
Hepatitis C (HCV) disproportionately affects people who inject drugs (PWID). Despite availability of safe and effective treatment, HCV treatment access and uptake among PWID in low- and middle-income countries (LMICs) has been limited. Understanding the lived experiences of PWID in these settings who have undergone treatment provides the opportunity to gain insight into how to implement treatment programs that meet the needs of this population. U…
Surveillance via wastewater monitoring and nasal self-collection of specimens (The SWANSS Study)
Given the political, structural, and organizational factors in a jail setting, innovations such as NST and WBS require a rigorous implementation strategy supported by ongoing engagement and collaboration with a multitude of stakeholders
Pre-Incarceration Healthcare Use and Access Barriers among Men with HIV and those at-Risk for Contracting HIV
Impact of scaling up harm reduction interventions on injecting risk behaviours, ART outcomes and HIV incidence among people who inject drugs in Kenya
This study provides strong evidence for the benefits of NSP and OAT on varied HIV outcomes among PWID in Africa
Differential risk for Hepatitis C and HIV among people who inject drugs in Kenya
Out of sight, into mind
Raising awareness of HBV, addressing social and structural barriers such as stigma and health insurance, and improving access to culturally sensitive programs among West African communities are needed to increase HBV screening, vaccination, and linkage to care
Co-designing the INHSU Prisons Hepatitis C Advocacy Toolkit using the Advocacy Strategy Framework
The Toolkit holds promise for progressing the WHO elimination goals by increasing advocacy efforts for enhanced prison HCV services globally. The co-design of Toolkit resources with potential end-users has increased its potential accessibility, acceptability, and inclusivity for a globally diverse audience
Barriers and advocacy needs for hepatitis C services in prisons
Perceived patient navigator services and characteristics to address barriers to linkage to hepatitis C care among people released from provincial prison in Quebec, Canada
Interventions that seek to improve linkage to HCV care for people following release from prison should address many levels (individual, interpersonal, and policy) of the SEM. While people experience several competing priorities post-release, having an empathetic and consistent patient navigator, regardless of their lived experiences of HCV and/or incarceration, may improve linkage to HCV care post-release
Four Models of Wastewater-Based Monitoring for Sars-CoV-2 Complementing Individual Screening in Jail Settings
Objectives. To describe 4 unique models of operationalizing wastewater-based surveillance (WBS) for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in jails of graduated sizes and different architectural designs. Methods. We summarize how jails of Cook County, Illinois (average daily population [ADP] 6000); Fulton County, Georgia (ADP 3000); Middlesex County, Massachusetts (ADP 875); and Washington, DC (ADP 1600) initiated WBS betwee…
Predictors of hepatitis C cure among people who inject drugs treated with directly observed therapy supported by peer case managers in Kenya
HIV And HCV adherence and treatment outcomes among people who inject drugs receiving opioid agonist therapy
Among people who inject drugs (PWID), 60% have HCV and 50–90% of HIV-infected PWID are co-infected with HCV. Data comparing adherence to direct-acting antiviral (DAA) therapy among HCV mono-infected and HIV/HCV co-infected PWID is limited. The impact of HCV treatment initiation on HIV antiretroviral therapy (ART) adherence is also poorly understood. We assessed DAA adherence in HCV mono-infected and HIV/HCV co-infected PWID and examined changes i…
Challenges and best practices for hepatitis C care among people who inject drugs in resource limited settings
People who inject drugs (PWID) living with Hepatitis C (HCV) in low- and middle-income countries face substantial barriers to HCV care. We sought to gain healthcare providers' perspectives on challenges and best practices for HCV care provision among PWID in Kenya. We conducted three focus group discussions (FGD) with 23 healthcare providers working with PWID living with HCV in Nairobi and Mombasa. Transcribed interviews were analysed thematicall…
Impact of Covid-19 on substance use disorder treatment services in Kenya
An intensive model of care for hepatitis C virus screening and treatment with direct‐acting antivirals in people who inject drugs in Nairobi, Kenya
BACKGROUND AND AIMS: Hepatitis C virus (HCV) treatment is essential for eliminating HCV in people who inject drugs (PWID), but has limited coverage in resource-limited settings. We measured the cost-effectiveness of a pilot HCV screening and treatment intervention using directly observed therapy among PWID attending harm reduction services in Nairobi, Kenya. DESIGN: We utilized an existing model of HIV and HCV transmission among current and forme…
Hepatitis C-related knowledge, attitudes and perceived risk behaviours among people who inject drugs in Kenya
Despite disproportionately high rates of Hepatitis C (HCV) among people who inject drugs (PWID) in low- and middle-income countries (LMICs), understanding of HCV-related knowledge, attitudes and perceived risk behaviours among this population remains limited. We aimed to elucidate knowledge, attitudes and experiences that could minimise transmission risk and maximise HCV treatment engagement among PWID in Kenya following the integration of HCV sc…
High HCV cure rates among people who inject drugs and have suboptimal adherence
Flattening the Curve for Incarcerated Populations — Covid-19 in Jails and Prisons
Flattening the Curve for Incarcerated Populations People caught up in the U.S. justice system have already been affected by SARS-CoV-2, and improved preparation is essential to minimizing the impac...
Gaps in HCV Knowledge and Risk Behaviors among Young Suburban People Who Inject Drugs
Hepatitis C virus (HCV) among young suburban people who inject drugs (PWID) is a growing epidemic in the United States, yet little is known about the factors contributing to increased exposure. The goal of this study was to explore and assess HCV knowledge and attitudes about treatment and identify risk behaviors among a cohort of young suburban PWID. Methods: We conducted interviews with New Jersey (NJ) service providers and staff from the state…
Drug Purchasing Strategies to Treat People With Hepatitis C in the Criminal Justice System
"Drug Purchasing Strategies to Treat People With Hepatitis C in the Criminal Justice System." , 108(5), pp. 607–608
Sin obras prominentes en esta página.
Hepatitis C Screening of the “Birth Cohort” (Born 1945–1965) and Younger Inmates of New York City Jails
Objectives. To examine uptake of screening for all individuals born between 1945 and 1965 (referred to by the Centers for Disease Control and Prevention as the “birth cohort”) and outline preliminary HCV prevalence data in the New York City jail system. Methods. Data were extracted from electronic health records for all individuals screened for HCV between June 13, 2013, and June 13, 2014, in New York City jails. We used the Abbott EIA 2.0 HCV an…
Drug Purchasing Strategies to Treat People With Hepatitis C in the Criminal Justice System
"Drug Purchasing Strategies to Treat People With Hepatitis C in the Criminal Justice System." , 108(5), pp. 607–608
Gaps in HCV Knowledge and Risk Behaviors among Young Suburban People Who Inject Drugs
Hepatitis C virus (HCV) among young suburban people who inject drugs (PWID) is a growing epidemic in the United States, yet little is known about the factors contributing to increased exposure. The goal of this study was to explore and assess HCV knowledge and attitudes about treatment and identify risk behaviors among a cohort of young suburban PWID. Methods: We conducted interviews with New Jersey (NJ) service providers and staff from the state…
Flattening the Curve for Incarcerated Populations — Covid-19 in Jails and Prisons
Flattening the Curve for Incarcerated Populations People caught up in the U.S. justice system have already been affected by SARS-CoV-2, and improved preparation is essential to minimizing the impac...
An intensive model of care for hepatitis C virus screening and treatment with direct‐acting antivirals in people who inject drugs in Nairobi, Kenya
BACKGROUND AND AIMS: Hepatitis C virus (HCV) treatment is essential for eliminating HCV in people who inject drugs (PWID), but has limited coverage in resource-limited settings. We measured the cost-effectiveness of a pilot HCV screening and treatment intervention using directly observed therapy among PWID attending harm reduction services in Nairobi, Kenya. DESIGN: We utilized an existing model of HIV and HCV transmission among current and forme…
Hepatitis C-related knowledge, attitudes and perceived risk behaviours among people who inject drugs in Kenya
Despite disproportionately high rates of Hepatitis C (HCV) among people who inject drugs (PWID) in low- and middle-income countries (LMICs), understanding of HCV-related knowledge, attitudes and perceived risk behaviours among this population remains limited. We aimed to elucidate knowledge, attitudes and experiences that could minimise transmission risk and maximise HCV treatment engagement among PWID in Kenya following the integration of HCV sc…
High HCV cure rates among people who inject drugs and have suboptimal adherence
HIV And HCV adherence and treatment outcomes among people who inject drugs receiving opioid agonist therapy
Among people who inject drugs (PWID), 60% have HCV and 50–90% of HIV-infected PWID are co-infected with HCV. Data comparing adherence to direct-acting antiviral (DAA) therapy among HCV mono-infected and HIV/HCV co-infected PWID is limited. The impact of HCV treatment initiation on HIV antiretroviral therapy (ART) adherence is also poorly understood. We assessed DAA adherence in HCV mono-infected and HIV/HCV co-infected PWID and examined changes i…
Challenges and best practices for hepatitis C care among people who inject drugs in resource limited settings
People who inject drugs (PWID) living with Hepatitis C (HCV) in low- and middle-income countries face substantial barriers to HCV care. We sought to gain healthcare providers' perspectives on challenges and best practices for HCV care provision among PWID in Kenya. We conducted three focus group discussions (FGD) with 23 healthcare providers working with PWID living with HCV in Nairobi and Mombasa. Transcribed interviews were analysed thematicall…
Impact of Covid-19 on substance use disorder treatment services in Kenya
Predictors of hepatitis C cure among people who inject drugs treated with directly observed therapy supported by peer case managers in Kenya
Out of sight, into mind
Raising awareness of HBV, addressing social and structural barriers such as stigma and health insurance, and improving access to culturally sensitive programs among West African communities are needed to increase HBV screening, vaccination, and linkage to care
Co-designing the INHSU Prisons Hepatitis C Advocacy Toolkit using the Advocacy Strategy Framework
The Toolkit holds promise for progressing the WHO elimination goals by increasing advocacy efforts for enhanced prison HCV services globally. The co-design of Toolkit resources with potential end-users has increased its potential accessibility, acceptability, and inclusivity for a globally diverse audience
Barriers and advocacy needs for hepatitis C services in prisons
Perceived patient navigator services and characteristics to address barriers to linkage to hepatitis C care among people released from provincial prison in Quebec, Canada
Interventions that seek to improve linkage to HCV care for people following release from prison should address many levels (individual, interpersonal, and policy) of the SEM. While people experience several competing priorities post-release, having an empathetic and consistent patient navigator, regardless of their lived experiences of HCV and/or incarceration, may improve linkage to HCV care post-release
Four Models of Wastewater-Based Monitoring for Sars-CoV-2 Complementing Individual Screening in Jail Settings
Objectives. To describe 4 unique models of operationalizing wastewater-based surveillance (WBS) for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in jails of graduated sizes and different architectural designs. Methods. We summarize how jails of Cook County, Illinois (average daily population [ADP] 6000); Fulton County, Georgia (ADP 3000); Middlesex County, Massachusetts (ADP 875); and Washington, DC (ADP 1600) initiated WBS betwee…
Barriers to and impacts of hepatitis C treatment among people who inject drugs in Kenya
Hepatitis C (HCV) disproportionately affects people who inject drugs (PWID). Despite availability of safe and effective treatment, HCV treatment access and uptake among PWID in low- and middle-income countries (LMICs) has been limited. Understanding the lived experiences of PWID in these settings who have undergone treatment provides the opportunity to gain insight into how to implement treatment programs that meet the needs of this population. U…
Surveillance via wastewater monitoring and nasal self-collection of specimens (The SWANSS Study)
Given the political, structural, and organizational factors in a jail setting, innovations such as NST and WBS require a rigorous implementation strategy supported by ongoing engagement and collaboration with a multitude of stakeholders
Pre-Incarceration Healthcare Use and Access Barriers among Men with HIV and those at-Risk for Contracting HIV
Impact of scaling up harm reduction interventions on injecting risk behaviours, ART outcomes and HIV incidence among people who inject drugs in Kenya
This study provides strong evidence for the benefits of NSP and OAT on varied HIV outcomes among PWID in Africa
Differential risk for Hepatitis C and HIV among people who inject drugs in Kenya
Budget impact of wastewater surveillance for Covid-19 in a large urban jail
Background: Correctional facilities were disproportionately affected by SARS-CoV-2 (COVID-19) outbreaks. Wastewater surveillance programs (WSP) may provide early warnings of the presence of COVID-19 and facilitate the timely implementation of infection mitigation, but their budgetary implications for correctional systems remain unclear. Methods: We conducted an activity-based costing analysis of a pilot WSP in a large urban jail. Costs borne by t…
Feasibility and acceptability of peer navigator-led directly-observed-therapy to promote concordance with antiretroviral therapy among criminal legal system-involved individuals
Gender differences in social networks of women and men who inject drugs in Kenya
Hepatitis C treatment in a jail setting
Jail-based HCV treatment initiation is feasible. However, individuals released with medication face challenges in linkage to care. Improved discharge planning and community linkage are critical to post-release treatment success
Medicine (19 obras) · HIV, Drug Use, Sexual Risk (18 obras) · Hepatitis C virus research (17 obras) · Hepatitis C (15 obras) · HIV/AIDS Research and Interventions (10 obras) · Virology (10 obras) · Environmental health (9 obras) · Family medicine (9 obras) · Nursing (9 obras) · Hepatitis B Virus Studies (8 obras)